办公室诊疗场所与医院环境下动静脉瘘创建与照护的比较
本研究回顾2016至2020年学术医院、社区医院及透析通路专属办公室实验室(OBL)连续创建的389例自体动静脉瘘(AVF),按手术与随访地点分为医院组、混合组和OBL组。OBL组围手术期并发症率1.6%低于医院门诊手术的6.4%(P=.043),成熟率更高、获批使用时间更短、功能通畅率更好。
要点
- OBL组围手术期并发症率1.6%,低于医院门诊手术的6.4%(P=.043)。
- 成熟率医院组54%低于混合组86%和OBL组93%(P<.001)。
- 获批使用平均时间OBL组52天、混合组66天、医院组98天(P<.001)。
核心结论
- 在透析通路专属OBL中创建外科AVF是安全的,与仅接受医院照护的患者相比,围手术期并发症更少、成熟率更高、功能通畅率更好且获批使用时间更短。
- 医院创建瘘管后转至OBL接受后续照护的患者也观察到类似结果。
- 在AV通路专属OBL中创建和照护透析通路与医院照护相比与结局改善相关。
研究设计与样本
- 回顾性比较研究,纳入2016至2020年学术医院、社区医院及OBL连续创建的所有门诊外科自体AVF,共389例。
- 按手术地点和术后通路相关照护分为三组:医院组138例、混合组125例、OBL组126例。
- 评估人口学、合并症、手术方式、并发症、成熟、通畅及维持性手术,中位随访34.7个月。
主要发现
- 三组人口学和合并症无差异;平均年龄59岁,男性占58%。
- 围手术期并发症率在医院门诊手术263例中为6.4%,在OBL手术126例中为1.6%(P=.043)。
- 成熟率医院组54%低于混合组86%和OBL组93%,与AVF类型无关(P<.001)。
- 获批使用平均时间OBL组52天、混合组66天、医院组98天(P<.001)。
- 医院组原发通畅率最高但功能通畅率最低;功能通畅每年手术次数医院组0.7次、混合组2.1次、OBL组2.1次(P<.001)。
临床怎么用
- 原文结论未据此给出具体推荐,仅报告在透析通路专属OBL中创建和照护AVF与结局改善相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluates and compares outcomes of arteriovenous fistulas (AVFs) created in a dialysis access-dedicated office-based laboratory (OBL) and outpatient hospital setting. METHODS: All consecutive outpatient surgical autologous AVFs created at an academic hospital, community hospital, and an OBL from 2016 to 2020 were reviewed. Demographics, comorbidities, surgical procedure, complications, maturation, patency, and procedures for maintenance were assessed from time of surgical evaluation to the latest available documentation. Complications, maturation, and patency were compared by location of surgery and postoperative access-related care, creating three groups: surgery and follow-up in hospital (hospital group), surgery in hospital and follow-up in an OBL (hybrid group), or surgery and follow-up in OBL (OBL group). RESULTS: We included 389 AVFs; 138 were in the hospital group, 125 in the hybrid group, and 126 in the OBL group. The median follow-up time was 34.7 months. The mean age was 59 years. Percentage of male patients was 58%. The three groups did not differ with respect to demographics and comorbidities. Peri-operative complication rate was 6.4% among 263 hospital outpatient procedures and 1.6% among 126 OBL procedures (P = .043). The maturation rate was lower in the hospital group (54%) than the hybrid (86%) and OBL (93%) groups, irrespective of AVF type (P < .001). The mean time to approval for use was 52 days in the OBL group, 66 days in the hybrid group, and 98 days in the hospital group (P < .001). The hospital group had the highest primary patency, but the lowest functional patency. During the follow-up period, there was a significant difference in number of procedures per year of functional patency, with 0.7 in the hospital group, 2.1 in the hybrid group, and 2.1 in the OBL group (P < .001). CONCLUSIONS: Surgical AVF creation in a dialysis access-dedicated OBL is safe and associated with fewer perioperative complications, higher maturation rate, better functional patency, and lower time to approval for use as compared with patients receiving hospital-based care only. Similar results were seen among hospital created fistula patients who received subsequent care at an OBL. Dialysis access creation and care in AV Access dedicated OBLs is associated with improved outcomes as compared with hospital-based care.
引用
- Panse NS, Mina GE, Yu Y, et al. Arteriovenous fistula creation and care in an office-based practice compared with hospital-based care. J Vasc Surg. 2025. PMID: 39800116. doi:10.1016/j.jvs.2025.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。